Beni-Suef University
11 imported, source-linked research records. Published in the last five years.
11 matching research records
Topic: Klotho therapies. Only records linked to Beni-Suef University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–11 of 11 matching records. Counts update as records arrive.
Betanin attenuates renal ischemia reperfusion injury in rats: Insights into NLRP3, molecular docking, and molecular dynamics simulation
August 2, 2026 · 1 citations · Open access
Open original record →Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways
November 3, 2025 · 14 citations · Open access
Open original record →Unraveling chemotherapy-evoked hepatic dysfunction: a deep dive into cyclophosphamide-related liver injury
September 27, 2025 · 15 citations · Open access
Open original record →Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury
August 29, 2025 · 17 citations
Open original record →Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1/2-Nrf2-caspase-3 signaling pathway
April 15, 2025 · 18 citations · Open access
Open original record →The potential of fibroblast growth factor-21 and adiponectin as diagnostic biomarkers for type 2 diabetes mellitus: differential levels in response to treatments
October 29, 2024 · 0 citations · Open access
Open original record →Potential roles for eNOS and NrF2 /HO-1 signaling in the ameliorative effect of lixisenatide on diabetes-induced kidney injury in rats and its amplification by ticagrelor co-administration
October 1, 2024 · 3 citations · Open access
Open original record →Ameliorative effect of lixisenatide on diabetic cardiovascular damage and its enhancement via ticagrelor co-administration in rats: possible role of eNOS and NrF2 /HO-1 signaling
June 1, 2024 · 0 citations · Open access
Open original record →From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
April 25, 2024 · 46 citations · Open access
Open original record →Linagliptin, a DPP ‐4 inhibitor, activates AMPK / FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
February 14, 2024 · 6 citations · Open access
Open original record →Molecular signaling pathways in an experimental model of Cardiorenal Syndrome
April 1, 2023 · 1 citations · Open access
Open original record →